JCI
44
7
EMN
40
5
DVA
62
5
BAC
38
3
BIIB
36
8
A
43
2
O
26
16
KHC
11
2
NWL
48
4
AA
27
5
CHRW
53
2
ROK
46
3
MMC
46
5
PFE
37
4
XOM
33
3
XYL
29
4
AES
47
4
AIZ
61
5
SLB
41
2
CI
35
2
JCI
44
7
EMN
40
5
DVA
62
5
BAC
38
3
BIIB
36
8
A
43
2
O
26
16
KHC
11
2
NWL
48
4
AA
27
5
CHRW
53
2
ROK
46
3
MMC
46
5
PFE
37
4
XOM
33
3
XYL
29
4
AES
47
4
AIZ
61
5
SLB
41
2
CI
35
2
Financhill
Back

Xtant Medical Holdings 10K Form

Sell
27

XTNT
Xtant Medical Holdings

Last Price:
$0.38
Seasonality Move:
20.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive XTNT News And Ratings

See the #1 stock for the next 7 days that we like better than XTNT

XTNT Financial Statistics

Sales & Book Value

Annual Sales: $91.3M
Cash Flow: $-3.8M
Price / Cash Flow: 0
Annual Sales: $0.33
Price / Book: 1.09

Profitability

EPS (TTM): -0.13000
Net Income (TTM): $-17.6M
Gross Margin: $55.5M
Return on Equity: -35.98%
Return on Assets: -18.59%

Xtant Medical Holdings Earnings Forecast

Key Xtant Medical Holdings Financial Ratios

  • The Gross Profit Margin over the past 16 years for XTNT is 60.75%.
  • The Selling, General & Administrative Expenses for XTNT have been equal to 70.41% of Gross Profit Margin.
  • The Research & Development expenses have been 1.46% of Revenue.
  • The Interest Expense is 445.15% of Operating Income.
  • The Net Earning history of XTNT is 0.72% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 8 years.

Xtant Medical Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: XTNT
CUSIP: 98420P
Website: xtantmedical.com

Debt

Debt-to-Equity Ratio: 0.76
Current Ratio: 2.12
Quick Ratio: 0.81

Price-to-Earnings

Trailing P/E Ratio: 36
Forward P/E Ratio: 0

XTNT Technical Analysis vs Fundamental Analysis

Sell
27
Xtant Medical Holdings (XTNT) is a Sell

Is Xtant Medical Holdings a Buy or a Sell?